Eli Lilly's weight loss drug combo shed 23% of body weight, topping its own blockbuster
- Eli Lilly 近 90 天出现 15 次
- 上一次：同一天稍早 · Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
发生了什么
EloraTZP, which pairs tirzepatide with experimental drug eloralintide, outperformed tirzepatide alone in a 48-week Phase 2 trial in patients with obesity and type 2 diabetes
摘要按规则整理自下方来源原文